XXXXXXXXXXXXX XXXXXXXXXX Sample Clauses

XXXXXXXXXXXXX XXXXXXXXXX. Xxxxxxxxxx Xxxxxx Board of Commissioners
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
XXXXXXXXXXXXX XXXXXXXXXX. 15.1 This Agreement shall be construed, governed, interpreted and applied in accordance with the laws of the State of Texas, U.S.A., except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted. 15.2 The parties hereto acknowledge that this Agreement sets forth the entire Agreement and understanding of the parties hereto as to the subject matter hereof, and shall not be subject to any change or modification except by the execution of a written instrument subscribed to by the parties hereto. 15.3 The provisions of this Agreement are severable, and in the event that any provisions of this Agreement shall be determined to be invalid or unenforceable under any controlling body of the law, such invalidity or unenforceability shall not in any way affect the validity or enforceability of the remaining provisions hereof. 15.4 LICENSEE agrees to make the LICENSED PRODUCTS sold in the United States with all applicable United States patent numbers. All LICENSED PRODUCTS shipped to or sold in other countries shall be marked in such a manner as to conform with the patent laws and practice of the country of manufacture or sale. 15.5 The failure of either party to assert a right hereunder or to insist upon compliance with any term or condition o this Agreement shall not constitute a waiver of that right or excuse a similar subsequent failure to perform any such term or condition by the other party.
Sample 1Sample 2
XXXXXXXXXXXXX XXXXXXXXXX. (x) This Agreement is an integrated agreement and, except for the agreements contemplated herein and the escrow instructions to accomplish this agreement (including the Undertakings Agreement), it contains the entire understanding between the parties with respect to the transaction contemplated herein, and all prior agreements, understandings, representations and statements, oral or written are merged into this Agreement. The delivery of the deed by Seller will be deemed the full performance and discharge of every obligation on the part of Seller to be performed hereunder, except for any obligations of Seller which are expressly provided herein to survive the closing. No provision of this Agreement may be waived except by an instrument signed by the party against whom the enforcement of such waiver is sought. All modifications (including any extensions) of this Agreement will be effective only if signed by Seller and Buyer. (b) This Agreement will be governed by, and construed in accordance with, the local, internal laws of the Commonwealth of Massachusetts applicable to agreements to be wholly performed therein, without regard to conflicts of laws. (c) This Agreement will be binding on and will inure to the benefit of the parties hereto and their respective successors and assigns, provided, however, that Buyer will not have the right or power to assign or transfer this Agreement. This Agreement and its terms are for the sole benefit of the parties hereto (including, without limitation, the released Seller's Affiliates) and their permitted successors and assigns, if any, and no other person or entity will have any right of action hereon or right to claim any right or benefit from this Agreement or its terms or be deemed a third party beneficiary hereunder. Except for the representations and warranties specifically set forth in this Agreement, there are no representations and warranties, express or implied, that are being made or relied on by the parties hereto. All representations, warranties and indemnities hereunder will survive the closing of this Agreement. (d) Notwithstanding anything to the contrary in the Lease or elsewhere, and without diminishing any amounts payable for the Purchase Price, as of and after the closing Buyer, as Tenant under the Lease and in all other capacities (and this Subsection 12(d) will be deemed to be an amendment of the Lease if and to the extent necessary), and on its own behalf and on behalf of Buyer's Affiliates, irrevoc...
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. The Board of Directors of the Louisiana Society of Health-System Pharmacists invites you to participate as an exhibitor and/or sponsor for the LSHP 2019 Mid Year Meeting, which will be held Saturday, September 28 at the Shreveport Convention Center, 000 Xxxxx Xx, Xxxxxxxxxx, XX 00000. Our Mid Year Meeting draws approximately 130-150 participants. This is a one-day meeting with the opportunity for our registrants to gain about 7 hours of continuing education credit. LSHP members represent more than 180 hospitals in Louisiana, many of which are clinical pharmacists and administrative decision makers at their institutions. As an exhibitor, you will receive one table at our exhibition for two representatives. Our exhibition area will be open from 11:00 a.m.-1:00 p.m. on Saturday, September 28, including an hour of exhibit time and an hour available for lunching with registrants allowing you a great opportunity to meet with LSHP pharmacists and pharmacy technicians one-on-one. This is an excellent business opportunity and a way to show your support of your local pharmacists. An exhibit agreement and registration are found on the following pages and should be submitted to LSHP at the above address. If you are interested in becoming a sponsor, there are many ways to support LSHP and the Mid Year Meeting. Sponsorship opportunities are listed on the fourth page and are available even if you are unable to attend the meeting. If you have any questions regarding exhibiting or sponsorship, please don’t hesitate to call Xxxxx Xxxxxx, Association Coordinator at the LSHP office. The LSHP tax id number is 72- 0859040. Again this year, LSHP is offering a “Reverse Expo,” on Friday, September 27th, 2019, where hospital pharmacy decision makers (pharmacy directors and/or clinical managers) will each host a table while vendors walk the floor. Please see page 7 of this document for more information! Your support of LSHP and its programs demonstrates your professional commitment and support of pharmacists in Louisiana. This support is both recognized and appreciated by the Board of Directors and membership of LSHP. On behalf of the Executive Committee and the Board of Directors of LSHP, we would like to thank you in advance for your continued support. Sincerely,
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. XXX’s and/or Xxxxxx Switzerland’s obligation, as applicable, to reimburse the Administrative Agent and the Lenders on account of any drawing under any Letter of Credit as provided in §4.2.
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. 00 A. Each administrator in the bargaining unit, who is not on the Probationary 19 Status, shall be issued a three (3) year contracts by the Board of Education, 20 renewable annually 22 B. During each of the first two (2) years of employment in the initial 23 administrative position, the administrator may be on probation. During the 24 probationary period administrators may be given a one (1) or two (2) year 25 contract. 27 C. The Board shall notify each administrator prior to March 1st of his/her 28 employment status for the next contract year or years. 30 D. By mutual agreement of both the Board of Education and the Jefferson 31 Administrators Association, this contract may be re-opened for negotiations. 33 E. The Board shall make the same payroll deductions available to 34 administrators as are made for other employees. 36 F. Administrators shall be covered under the District’s Comprehensive Liability 37 Policy 39 G. Professional organization dues for membership in the State and National 40 organizations shall be paid by the Board for each Association Member. 41 42 H. Members of the Association shall not acquire Tenure in any position covered 43 by this contract to which they may be assigned. 44 45 47 48 4 A. Health Insurance 5
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. Xxxxx Xxxxxx GlaxoSmithKline’s manufacturing business at Cape Town Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Mexico GlaxoSmithKline’s manufacturing business at Civac Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Australia GlaxoSmithKline’s manufacturing business at Ermington Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Ireland GlaxoSmithKline’s manufacturing business at Sligo Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. UK GlaxoSmithKline’s manufacturing business at Maidenhead GlaxoSmithKline’s manufacturing business at Slough (Excluding employees) Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. US GlaxoSmithKline’s manufacturing business at Oak Hill GlaxoSmithKline’s manufacturing business at St Louis GlaxoSmithKline’s manufacturing business at Aiken (Excluding employees) Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling.
Sample 1
AutoNDA by SimpleDocs

Related to XXXXXXXXXXXXX XXXXXXXXXX

  • Xxxxxxxx Xxxxxxxxx Xx xxxvided for in the Agreement and Declaration of Trust of the various Funds, under which the Funds are organized as unincorporated trusts, the shareholders, trustees, officers, employees and other agents of the Fund shall not personally be found by or liable for the matters set forth hereto, nor shall resort be had to their private property for the satisfaction of any obligation or claim hereunder.

  • Xxxxxxxxxxxxx The captions in this Agreement are included for convenience of reference only, and in no way define or delimit any of the provisions hereof or otherwise affect their construction or effect. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

  • Xxxxxxxxxxxx This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

  • Xxxxxxx Xxxxxxxxx This Lot may contain Bundles which include Hardware and/or Software in combination with Cloud Services. All components of the Bundle must be within the overall scope of this Contract. The Hardware or Software Products included in the Bundle cannot be listed as stand-alone items for this Lot. Third Party Products are allowed as part of a Bundle only if they are required to facilitate the provision of the Cloud solution. Contractor is responsible for providing physical and logical security for all Data, infrastructure (e.g. hardware, networking components, physical devices), and software related to the services the Contractor is providing under the Authorized User Agreement. All Data security provisions agreed to by the Authorized User and Contractor within the Authorized User Agreement may not be diminished for the duration of the Authorized User Agreement. No reduction in these conditions in any fashion may occur at any time without prior written agreement by the parties amending the Authorized User Agreement.

  • Xxxxxxxx Xxxxxxxx obligation to pay compensation to PaineWebber as agreed upon pursuant to this paragraph 4 is not contingent upon receipt by Xxxxxxxx Xxxxxxxx of any compensation from the Fund or Series. Xxxxxxxx Xxxxxxxx shall advise the Board of any agreements or revised agreements as to compensation to be paid by Xxxxxxxx Xxxxxxxx to PaineWebber at their first regular meeting held after such agreement but shall not be required to obtain prior approval for such agreements from the Board.

  • Xxxxxx Xxxxxxxxxx Name: D. Xxxxxx Xxxxxxxxxx Title: President and CEO

  • Xxxxxxxxxxxxxx XX.Xxx as a Microsoft Excel Spreadsheet or some other mutually agreeable standardized format (CSV, MDB, etc.).

  • Xxxxxxxxxxxxxxx Xx the fullest extent permitted by the Act, as the same now exists or may hereafter be amended, substituted or replaced (but, in the case of any such amendment, substitution or replacement only to the extent that such amendment, substitution or replacement permits the Company to provide broader indemnification rights than the Act permitted the Company to provide prior to such amendment, substitution or replacement), the Company shall indemnify, hold harmless, defend, pay and reimburse any Covered Person against any and all losses, claims, damages, judgments, fines or liabilities, including reasonable legal fees or other expenses incurred in investigating or defending against such losses, claims, damages, judgments, fines or liabilities, and any amounts expended in settlement of any claims (collectively, "Losses") to which such Covered Person may become subject by reason of any act or omission or alleged act or omission performed or omitted to be performed by such Covered Person on behalf of the Company in connection with the business of the Company, including pursuant to the Management Agreement; provided, that (i) such Covered Person acted in good faith and in a manner believed by such Covered Person to be in, or not opposed to, the best interests of the Company and, with respect to any criminal proceeding, had no reasonable cause to believe his conduct was unlawful, and (ii) such Covered Person's conduct did not constitute fraud or willful misconduct, in either case as determined by a final, nonappealable order of a court of competent jurisdiction. In connection with the foregoing, the termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the Covered Person did not act in good faith or, with respect to any criminal proceeding, had reasonable cause to believe that such Covered Person's conduct was unlawful, or that the Covered Person's conduct constituted fraud or willful misconduct.

  • Xxxxxxxxxxx 12.1 In addition to the specific rights of termination set out in the Clause "The Publisher's Responsibilities" and the Clause "The Author's Responsibilities", either Party shall be entitled to terminate this Agreement forthwith by notice in writing to the other Party if the other Party commits a material breach of the terms of the Agreement which cannot be remedied or, if such breach can be remedied, fails to remedy such breach within 45 days of being given written notice to do so. 12.2 Termination of this Agreement, howsoever caused, shall not affect: (a) any subsisting rights of any third party under any licence or sub-licence validly granted by the Publisher prior to termination and the Publisher shall be entitled to retain its share of any sum payable by any third party under any such licence or sub-licence; (b) except where stated otherwise in this Agreement, any claim which either Party may have against the other for damages or otherwise in respect of any rights or liabilities arising prior to the date of termination; (c) the Publisher’s right to continue to sell any copies of the Work which are in its power, possession or control as at the date of expiry or termination of this Agreement for a period of 6 months on a non-exclusive basis.

  • xxxxxxxxxxxxxxxx xxx and log in to view your Reward Point earnings ratio for every qualifying purchase dollar amount. A qualifying purchase (“Qualifying Transaction”) shall mean: (i) a transaction that is charged to an eligible card account covered by the Program (“Account”), and

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!